Working Groups
CGC Working Groups create evidence-based reviews and practice considerations that positively impact the appropriate utilization and reimbursement of genomic testing in cancer. Through this work, they play a central role in advancing the Cancer Genomics Consortium’s mission to promote the highest standards in clinical genomics, support scientific innovation, and improve patient care.
In this forum, Working Groups bring together members from across our multidisciplinary community to collaborate, share expertise, and address emerging challenges in cancer genomics. By fostering teamwork, personal growth, professional development, and scientific achievement, these groups strengthen the collective knowledge base and help ensure that evolving genomic technologies are applied responsibly and effectively.
We are grateful to the Working Groups who have completed their projects, and we deeply appreciate the authors for their time, expertise, and dedication. Their contributions help drive the CGC mission forward and support the continued advancement of clinical cancer genomics.
Active CGC Working Groups
Artificial Intelligence (AI) and Machine Learning (ML) in Clinical Genomics Working Group
Leader: Greg Corboy and Min Fang
CGC Board Liaison: TBD
Breast Cancer Working Group
Leaders: Hui Chen and Katherine Geiersbach
CGC Board Liaison: Adam Smith
Clinical Implementation of Multimodal Liquid Biopsy Cancer Testing Working Group
Leader: Alyssa Parker and Shiva Sathyanarayana
CGC Board Liaison: Trevor Pugh
Clinically Significant Genes in CNS Tumors Working Group
Leader: Madina Sukhanoa and Laveniya Satgunaseelan
CGC Board Liaison: Angela Lager
Compendium of Cancer Genome Aberrations (CCGA) Working Group
Editor in Chief: Jennelle Hodge
Creation and Maintenance of Disease-Specific Gene Lists to Aid in Cancer Genome Interpretation
Leaders: Beth Pitel and Xinjie Xu
CGC Board Liaison: Trevor Pugh
Macrogenomic Event Detection in Solid Tumors Working Group
Leader: Lisa Lansdon
CGC Board Liaison: Trevor Pugh
Molecular Cancer Testing in Underserved Communities Working Group
Leader: Thuy Phung
CGC Board Liaison: Niroshi Senaratne
Plasma Cell Neoplasms - Molecular Testing Working Group
Leader: Celeste Eno
CGC Board Liaison: Celeste Eno
Predisposition to Hematologic Malignancies Working Group
Leader: Minjie Luo and Huan Mo
CGC Board Liaison: TBD
Somatic Overgrowth and Vascular Anomalies Working Group
Leaders: Avinash Dharmadhikari and Yang Cao
CGC Board Liaison: Cate Paschal
Towards Clinical Implementation of Genome Mapping and Long-Read Sequencing Methodologies for Comprehensive Structural and Epigenomic Profiling
Leaders: Sara Akhavanfard and Avinash Dharmadhikari
CGC Board Liaison: TBD